This Injectable Hydrogel Mitigates Damage to the Right Ventricle of the Heart

An injectable hydrogel can mitigate damage to the right ventricle of the heart with chronic pressure overload, according to a new study published March 6 in Journals of the American College of Cardiology: Basic to Translational Science.  The study, by a research team from the University of California San Diego, Georgia Institute of Technology and Emory University, was conducted in rodents.

Breaching the Blood-Brain Barrier to Deliver Precious Payloads

RNA-based drugs may change the standard of care for many diseases, making personalized medicine a reality. So far these cost-effective, easy-to-manufacture drugs haven’t been very useful in treating brain tumors and other brain disease. But a team of researchers at Georgia Tech and Emory University has shown that a combination of ultrasound and RNA-loaded nanoparticles can temporarily open the protective blood-brain barrier, allowing the delivery of potent medicine to brain tumors.

Adjusting Processing Temperature Results in Better Hydrogels for Biomedical Applications

Biohydrogels have been studied closely for their potential use in biomedical applications, but they often move between sols and gels, depending on their temperature, changes that can pose issues depending on the intended use. In Physics of Fluids, researchers discuss their work studying the effect of temperature on hydrogels. They found that creating hydrogels at room temperature or below results in more robust materials that function more effectively when used in the body.